• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型卡维地洛己二酸和琥珀酸乙醇溶剂化物盐的特性和晶体结构分析。

Characterization and Crystal Structural Analysis of Novel Carvedilol Adipate and Succinate Ethanol-Solvated Salts.

机构信息

Department of Physical Chemistry, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, 2-4-41 Ebara, Shinagawa-ku 142-8501, Tokyo, Japan.

Juntendo University Faculty of Pharmacy, 6-8-1 Hinode, Urayasu 279-0013, Chiba, Japan.

出版信息

Molecules. 2024 Oct 4;29(19):4704. doi: 10.3390/molecules29194704.

DOI:10.3390/molecules29194704
PMID:39407632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11478148/
Abstract

Two ethanol-solvated adipate and succinate salts of carvedilol (CVD), a Biopharmaceutics Classification System class 2 drug, were synthesized by crystallizing ethanol with adipic acid (ADP) and succinic acid (SUA). Proton transfer from ADP and SUA to CVD and the presence of ethanol in the two novel compounds were confirmed using powder X-ray diffraction, Fourier transform infrared spectroscopy, differential scanning calorimetry, thermogravimetric analysis, and single-crystal X-ray diffraction measurements. The two novel ethanol-solvated salts exhibited enhanced solubility and dissolution rates compared with pure carvedilol in phosphate buffer (pH 6.8). Additionally, the morphologies and attachment energies of the two novel compounds and pure CVD were calculated based on their single-crystal structures, revealing a correlation between attachment energy and dissolution rate.

摘要

两种乙醇溶剂化的卡维地洛(CVD)己二酸和琥珀酸盐(CVD),一种生物药剂学分类系统(BCS)分类为 2 类药物,通过与己二酸(ADP)和琥珀酸(SUA)共结晶乙醇合成。通过粉末 X 射线衍射、傅里叶变换红外光谱、差示扫描量热法、热重分析和单晶 X 射线衍射测量,证实了 ADP 和 SUA 向 CVD 的质子转移以及两种新化合物中乙醇的存在。与纯卡维地洛相比,两种新型乙醇溶剂化盐在磷酸盐缓冲液(pH 6.8)中表现出更高的溶解度和溶解速率。此外,根据它们的单晶结构计算了两种新型化合物和纯 CVD 的形态和附着能,揭示了附着能与溶解速率之间的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/5de06d600e60/molecules-29-04704-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/f43378b990e7/molecules-29-04704-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/16d306d9d10b/molecules-29-04704-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/c6e3601070d1/molecules-29-04704-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/57d28ae093c4/molecules-29-04704-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/78de37e4c158/molecules-29-04704-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/461597988d9f/molecules-29-04704-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/3d41ef2ca0e4/molecules-29-04704-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/d985bc7170a8/molecules-29-04704-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/d194fe4238cd/molecules-29-04704-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/85d85aa353a8/molecules-29-04704-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/c2fcc8865598/molecules-29-04704-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/5de06d600e60/molecules-29-04704-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/f43378b990e7/molecules-29-04704-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/16d306d9d10b/molecules-29-04704-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/c6e3601070d1/molecules-29-04704-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/57d28ae093c4/molecules-29-04704-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/78de37e4c158/molecules-29-04704-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/461597988d9f/molecules-29-04704-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/3d41ef2ca0e4/molecules-29-04704-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/d985bc7170a8/molecules-29-04704-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/d194fe4238cd/molecules-29-04704-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/85d85aa353a8/molecules-29-04704-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/c2fcc8865598/molecules-29-04704-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4795/11478148/5de06d600e60/molecules-29-04704-g012.jpg

相似文献

1
Characterization and Crystal Structural Analysis of Novel Carvedilol Adipate and Succinate Ethanol-Solvated Salts.新型卡维地洛己二酸和琥珀酸乙醇溶剂化物盐的特性和晶体结构分析。
Molecules. 2024 Oct 4;29(19):4704. doi: 10.3390/molecules29194704.
2
Solid-state characterization of novel active pharmaceutical ingredients: cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt.新型活性药物成分的固态特性研究:沙丁胺醇己二酸半酯盐(2:1:1)与沙丁胺醇富马酸盐的共晶。
J Pharm Sci. 2011 Aug;100(8):3268-3283. doi: 10.1002/jps.22569. Epub 2011 Apr 6.
3
Pharmaceutical Salts of Carvedilol: Polymorphism and Physicochemical Properties.卡维地洛的药用盐:多晶型现象及物理化学性质
AAPS PharmSciTech. 2017 May;18(4):1417-1425. doi: 10.1208/s12249-016-0616-x. Epub 2016 Sep 6.
4
Evaluation and correlation of the physicochemical properties of carvedilol.卡维地洛理化性质的评估与关联
Pharm Dev Technol. 2016 Nov;21(7):856-866. doi: 10.3109/10837450.2015.1073740. Epub 2015 Aug 31.
5
New multi-component solid forms of anti-cancer drug Erlotinib: role of auxiliary interactions in determining a preferred conformation.抗癌药物厄洛替尼的新型多组分固体形式:辅助相互作用在确定优选构象中的作用。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Jun 1;72(Pt 3):291-300. doi: 10.1107/S2052520616003607. Epub 2016 May 13.
6
Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.去甲文拉法辛草酸氢盐的晶体形式。
J Pharm Pharmacol. 2015 Jun;67(6):823-9. doi: 10.1111/jphp.12378. Epub 2015 Feb 3.
7
Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.与 Gelucire 50/13 形成固体分散体提高卡维地洛的溶解度和理化特性。
Arch Pharm Res. 2011 Jan;34(1):51-7. doi: 10.1007/s12272-011-0106-3. Epub 2011 Apr 6.
8
Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid.形成和物理化学性质的结晶和无定形盐与不同的化学计量形成之间的环丙沙星和琥珀酸。
Mol Pharm. 2013 Oct 7;10(10):3640-54. doi: 10.1021/mp400127r. Epub 2013 Aug 30.
9
Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.卡维地洛在旋转纺丝微纤维中的晶态-非晶态转变跟踪及其制成口腔崩解片以增强体外溶出度的制剂研究。
J Pharm Biomed Anal. 2015 Nov 10;115:359-67. doi: 10.1016/j.jpba.2015.07.042. Epub 2015 Jul 30.
10
Pharmaceutical salts of ciprofloxacin with dicarboxylic acids.环丙沙星与二羧酸形成的药用盐
Eur J Pharm Sci. 2015 Sep 18;77:112-21. doi: 10.1016/j.ejps.2015.06.004. Epub 2015 Jun 9.

本文引用的文献

1
Characterization of co-amorphous carvedilol-maleic acid system prepared by solvent evaporation.溶剂蒸发法制备的共无定形卡维地洛-马来酸体系的表征
Pharm Dev Technol. 2023 Mar-Apr;28(3-4):309-317. doi: 10.1080/10837450.2023.2194406. Epub 2023 Apr 3.
2
Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs.药物共晶的晶体工程在改进药物的发现与开发中的应用
Chem Rev. 2022 Jul 13;122(13):11514-11603. doi: 10.1021/acs.chemrev.1c00987. Epub 2022 Jun 1.
3
Understanding Crystal Cleavability and Physical Properties of Crystal Surfaces Using in Silico Simulation.
使用计算机模拟理解晶体的可裂解性和晶体表面的物理性质。
Chem Pharm Bull (Tokyo). 2021;69(2):185-198. doi: 10.1248/cpb.c20-00719.
4
Binary polymeric amorphous carvedilol solid dispersions: In vitro and in vivo characterization.二元聚合物无定形卡维地洛固体分散体的研究:体外和体内特性分析。
Eur J Pharm Sci. 2020 Jul 1;150:105343. doi: 10.1016/j.ejps.2020.105343. Epub 2020 May 4.
5
Crystal Morphology Prediction and Anisotropic Evolution of 1,1-Diamino-2,2-dinitroethylene (FOX-7) by Temperature Tuning.通过温度调控对1,1-二氨基-2,2-二硝基乙烯(FOX-7)的晶体形态预测及各向异性演化
Sci Rep. 2020 Feb 11;10(1):2317. doi: 10.1038/s41598-020-59261-3.
6
Influence of preparation technique on co-amorphization of carvedilol with acidic amino acids.制备技术对卡维地洛与酸性氨基酸共无定形的影响。
Int J Pharm. 2018 Dec 1;552(1-2):407-413. doi: 10.1016/j.ijpharm.2018.09.070. Epub 2018 Sep 29.
7
Salts of Therapeutic Agents: Chemical, Physicochemical, and Biological Considerations.治疗剂的盐:化学、物理化学和生物学考虑因素。
Molecules. 2018 Jul 14;23(7):1719. doi: 10.3390/molecules23071719.
8
Mechanistic Basis of Cocrystal Dissolution Advantage.共晶溶解优势的机制基础。
J Pharm Sci. 2018 Jan;107(1):380-389. doi: 10.1016/j.xphs.2017.09.014. Epub 2017 Oct 6.
9
Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges.药物辅料的盐形式和共晶形式的药物活性成分及其特性研究。
Adv Drug Deliv Rev. 2017 Aug 1;117:86-110. doi: 10.1016/j.addr.2017.07.001. Epub 2017 Jul 5.
10
Pharmaceutical Salts of Carvedilol: Polymorphism and Physicochemical Properties.卡维地洛的药用盐:多晶型现象及物理化学性质
AAPS PharmSciTech. 2017 May;18(4):1417-1425. doi: 10.1208/s12249-016-0616-x. Epub 2016 Sep 6.